Explore
Trendline
Boston Scientific's SEISMIQ 4CE Catheter Achieves Key Safety and Effectiveness Milestones in Coronary Disease Trial
Boston Scientific's SEISMIQ 4CE Catheter Achieves Key Safety and Effectiveness Milestones in Coronary Disease Trial
Read More
Trendline
Stryker's AVS Enrolls First Patient in Coronary Intravascular Lithotripsy Study
Stryker's AVS Enrolls First Patient in Coronary Intravascular Lithotripsy Study
Read More
Trendline
AI Transforms Medical Device Industry with New Growth Opportunities
AI Transforms Medical Device Industry with New Growth Opportunities
Read More
Trendline
Tulyp Medical Appoints Steve Motes as CEO to Drive U.S. Growth in Medical Device Sector
Tulyp Medical Appoints Steve Motes as CEO to Drive U.S. Growth in Medical Device Sector
Read More
Trendline
Stryker's AVS Enrolls First Patient in Coronary Intravascular Lithotripsy Study, Aiming to Treat Calcified Arterial Disease
Stryker's AVS Enrolls First Patient in Coronary Intravascular Lithotripsy Study, Aiming to Treat Calcified Arterial Disease
Read More
Trendline
PorTal Access, Inc. Completes FDA 510(k) Submission for Flexi-Port, Paving Way for Oncology Device Launch
PorTal Access, Inc. Completes FDA 510(k) Submission for Flexi-Port, Paving Way for Oncology Device Launch
Read More
Trendline
Orthofix Medical Inc. to Engage in June 2026 Investor Conferences, Highlighting Healthcare Innovations
Orthofix Medical Inc. to Engage in June 2026 Investor Conferences, Highlighting Healthcare Innovations
Read More
Trendline
Route 92 Medical Appoints Raj Denhoy as Chief Financial Officer to Drive Growth
Route 92 Medical Appoints Raj Denhoy as Chief Financial Officer to Drive Growth
Read More
Trendline
Boston Scientific Initiates $2 Billion Accelerated Share Repurchase to Enhance Shareholder Value
Boston Scientific Initiates $2 Billion Accelerated Share Repurchase to Enhance Shareholder Value
Read More
Trendline
KORU Medical Systems Showcases Benefits of FreedomEDGE Infusion System at Oncology Nursing Congress
KORU Medical Systems Showcases Benefits of FreedomEDGE Infusion System at Oncology Nursing Congress
Read More
Trendline
Boston Scientific Invests $1.5 Billion in MiRus LLC for Cardiovascular Innovations
Boston Scientific Invests $1.5 Billion in MiRus LLC for Cardiovascular Innovations
Read More
Trendline
BD Appoints Peter Menziuso as EVP and President of BD Interventional, Aiming for Continued Growth
BD Appoints Peter Menziuso as EVP and President of BD Interventional, Aiming for Continued Growth
Read More